Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Non-Current Deffered Revenue: 2020

Historic Non-Current Deffered Revenue for Genmab A (GMAB) over the last 1 years, with Dec 2020 value amounting to $56.6 million.

  • Genmab A's Non-Current Deffered Revenue rose 15.01% to $57.83 in Q2 2021 from the same period last year, while for Jun 2021 it was $57.83, marking a year-over-year increase of 15.01%. This contributed to the annual value of $56.6 million for FY2020, which is N/A change from last year.
  • Per Genmab A's latest filing, its Non-Current Deffered Revenue stood at $56.6 million for FY2020.
  • Over the past 5 years, Genmab A's Non-Current Deffered Revenue peaked at $56.6 million during FY2020, and registered a low of $56.6 million during FY2020.
  • For the 1-year period, Genmab A's Non-Current Deffered Revenue averaged around $56.6 million, with its median value being $56.6 million (2020).